HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Zangeneh, F. Articles by Rizza, R. A. Search for Related Content PubMed PubMed Citation Articles by Zangeneh, F. Articles by Rizza, R. A.

Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia

Divisions of ¹Endocrinology, Metabolism, and Internal Medicine and Nutrition and ²Gastroenterology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905

Submitted 6 February 2003 ; accepted in final form 19 March 2003

Portal infusion of glucose at rates approximating endogenous glucose production (EGP) causes paradoxical hypoglycemia in wild-type but not GLUT2 null mice, implying activation of a specific portal glucose sensor. To determine whether this occurs in humans, glucose containing [3-³H]glucose was infused intraduodenally at rates of 3.1 mg · kg^-1 · min^-1 (n = 5), 1.55 mg · kg^-1 · min^-1 (n = 9), or 0/0.1 mg · kg^-1 · min^-1 (n = 9) for 7 h in healthy nondiabetic subjects. [6,6-²H₂]glucose was infused intravenously to enable simultaneous measurement of EGP, glucose disappearance, and the rate of appearance of the intraduodenally infused glucose. Plasma glucose concentrations fell (P < 0.01) from 90 ± 1 to 84 ± 2 mg/dl during the 0/0.1 mg · kg^-1 · min^-1 id infusions but increased (P < 0.001) to 104 ± 5 and 107 ± 3 mg/dl, respectively, during the 1.55 and 3.1 mg · kg^-1 · min^-1 id infusions. In contrast, insulin increased (P < 0.05) during the 1.55 and 3.0 mg · kg^-1 · min^-1 infusions, reaching a peak of 10 ± 2 and 18 ± 5 µU/ml, respectively, by 2 h. Insulin concentrations then fell back to concentrations that no longer differed by study end (7 ± 1 vs. 8 ± 1 µU/ml). This resulted in comparable suppression of EGP by study end (0.84 ± 0.2 and 0.63 ± 0.1 mg · kg^-1 · min^-1). Glucose disappearance was higher (P < 0.01) during the final hour of the 3.1 than 1.55 mg · kg^-1 · min^-1 id infusion (4.47 ± 0.2 vs. 2.6 ± 0.1 mg · kg^-1 · min^-1), likely because of the slightly, but not significantly, higher glucose and insulin concentrations. We conclude that, in contrast to mice, selective portal glucose delivery at rates approximating EGP does not cause hypoglycemia in humans.

portal signal; splanchnic glucose extraction; glucose uptake; endogenous glucose production

This article has been cited by other articles:

				A. C. Ertl, S. Mann, A. Richardson, V. J. Briscoe, H. B. Blair, D. B. Tate, and S. N. Davis Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E618 - E625. [Abstract] [Full Text] [PDF]

				F.-Y. Chueh, C. Malabanan, and O. P. McGuinness Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1206 - E1211. [Abstract] [Full Text] [PDF]

				N. Ogihara, W. Kawamura, K. Kasuga, Y. Hayashi, H. Arakawa, and M. Kikuchi Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E932 - E940. [Abstract] [Full Text] [PDF]

				M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF]